<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=314834185700910&amp;ev=PageView&amp;noscript=1">

New Update: Healthcare Costs Increasing by Over 60% in Some States. Will you be impacted?

Learn More

Navigating Market Challenges: Essential Insights for Catalent Employees Amidst Tech Sector Volatility

image-table

Healthcare Provider Update: Healthcare Provider for Catalent Catalent, a prominent player in the biopharmaceutical industry, collaborates with various healthcare providers to optimize its services. One of the notable healthcare partners for Catalent is UnitedHealthcare, which often works with organizations like Catalent to ensure streamlined processes in drug delivery and related healthcare services. Potential Healthcare Cost Increases in 2026 In 2026, healthcare costs are expected to rise significantly, primarily driven by looming federal policies and medical inflation. Reports indicate that Affordable Care Act (ACA) premiums may surge due to the potential expiration of enhanced premium subsidies, causing many policyholders to face out-of-pocket increases of over 75%. Insurers are already proposing steep rate hikes, with some states expected to see increases as high as 66%. This combination of factors, including rising healthcare service costs and more aggressive premium strategies from insurers, is set to intensify financial pressures on consumers in the coming year. Click here to learn more

Q1 2026 brought a striking divergence to technology markets. While the broader S&P 500 finished the quarter with a modest gain of approximately 2.4%, the technology sector experienced what analysts have dubbed the "SaaSpocalypse" - a sharp correction in business software valuations triggered by the rapid advancement of AI agents. Between January and mid-March 2026, an estimated $2 trillion in market capitalization evaporated from the software sector, with many SaaS companies seeing share prices decline 25% to 60%. Meanwhile, AI infrastructure providers and select defensive sectors surged. For employees with significant exposure to technology holdings, this divergence serves as a stark reminder that concentration in any single sector - even one that has driven market returns for years - carries meaningful risk.


What's triggering tech sector volatility? Throughout 2025, businesses across the U.S., like Catalent, navigated a market environment shaped by the Federal Reserve's gradual interest rate reductions and surging AI-driven investment. But in early 2026, the rapid deployment of AI agents began disrupting traditional software business models at a pace that caught many investors off guard. Companies that had built high-growth recurring-revenue software businesses saw their valuations slashed as AI tools threatened to automate entire categories of knowledge work. At the same time, the extraordinary concentration of the S&P 500 in a handful of mega-cap technology names amplified the volatility. The Magnificent Seven - Apple, Microsoft, Nvidia, Amazon, Alphabet, Meta, and Tesla - now account for approximately 35% of the S&P 500 by market capitalization, meaning their performance has an outsized influence on index returns. When sentiment shifted in early 2026, the resulting sector rotation - out of high-growth software and into defensive names, energy, and value stocks - moved quickly.


The downside of domination
Stocks tracked by the S&P Information Technology Sector Index experienced sharp divergence in Q1 2026, with software and SaaS names hit hardest while AI infrastructure names outperformed. Plus, like many benchmark indexes, the S&P 500 is weighted by market capitalization (the value of a company's outstanding shares). This gives the largest companies, most of which are in the tech sector, an outsized role in index performance. As of May 31, the information technology sector now accounts for approximately 31% of the market cap of the S&P 500 - up significantly from years prior - compared with weightings of roughly 13% for financials and 12% for healthcare, the next-largest sectors. Nvidia, Apple, and Microsoft are among the three most-valuable companies in the index, with the full Magnificent Seven (Nvidia, Apple, Microsoft, Amazon, Alphabet, Meta, and Tesla) collectively representing approximately 35% of the entire index. 7

For the past several years, tech stock gains drove the market to new heights, but when their share values began to plunge, they dragged the broader stock indexes down with them. Research shows that the Magnificent Seven were responsible for approximately 42% of the S&P 500's total annual return in 2025 - a level of concentration that makes the broader index highly sensitive to shifts in sentiment toward any of these companies. 8

These well-known technology companies have grown into massive multinational businesses that have a major influence on everyday life. Some dominate their respective business spaces — social media, smartphones, online search and advertising, e-commerce, and cloud computing — enough to spark antitrust investigations and calls for stricter regulations in the United States and abroad. They also have plenty of cash on hand, which means they may be in better shape to withstand an economic slowdown than their smaller competitors. 9

Articles you may find interesting:

Loading...


Takeaways for investors
Spreading investments among the 11 sectors of the S&P 500 is a common way to diversify stock holdings. But over time, a stock portfolio that was once diversified can become overconcentrated in a sector that has outperformed the broader market. Tech-sector stocks delivered strong total returns during 2023 through 2025, with AI-driven names generating outsized gains, so Catalent employees and retirees may want to look closely at the composition of their portfolio and consider rebalancing if they find themselves overexposed to this highly volatile sector. (Rebalancing involves selling some investments in order to buy others. Keep in mind that selling investments in a taxable account could result in a tax liability.)  10

If you feel shell-shocked after the recent market turbulence, we suggest our clients from Catalent try to regain some perspective. Some market analysts view recent price declines as a painful but long overdue repricing of stocks with valuations that had grown excessive, as well as a reality check brought on by waning growth expectations. The forward price-to-earnings (P/E) ratio of companies in the S&P 500 reached approximately 22.5x heading into 2026 - approaching historical highs - before the Q1 2026 correction brought it modestly lower. 11-12

It could be a while before investors can better assess how the economy and corporate profits will ultimately fare against AI-driven structural shifts and sector rotation pressures — and the stock market is no fan of uncertainty. Disappointing economic data and company earnings reports could continue to spark volatility in the coming months. 

It may not be easy to take troubling headlines in stride, but if you have a sufficiently diversified, all-weather investment strategy, sticking to it is often the wisest course of action. If you panic and flee the market during a downturn, you won't be in a position to benefit from upward swings on its better days. And if you continue investing regularly for a long-term goal such as retirement, a down market may be an opportunity to buy more shares at lower prices.

The return and principal value of stocks fluctuate with changes in market conditions. Shares, when sold, may be worth more or less than their original cost. Investments seeking a higher return tend to involve greater risk. Diversification is a method we suggest to our clients from Catalent; it's used to help manage risk, but it's also important that Catalent employees note that it doesn't guarantee a profit or protect against investment loss. The S&P 500 is an unmanaged group of securities that is considered representative of the U.S. stock market in general. The performance of an unmanaged index is not indicative of the performance of any specific investment. Individuals cannot invest directly in an index. Past performance is not a guarantee of future results. Actual results will vary. Dollar-cost averaging does not ensure a profit or prevent a loss. Such plans involve continuous investments in securities regardless of fluctuating prices. Catalent employees and retirees should consider their financial ability to continue making purchases during periods of low and high price levels. However, this can be an effective way for investors to accumulate shares to help meet long-term goals.

1) SIFMA, 2022
2) Yahoo! Finance, 2022
3) The New York Times, May 31, 2022
4, 7, 10-11) S&P Dow Jones Indices, 2022
5) U.S. Bureau of Labor Statistics, 2022
6) Federal Reserve, 2022
8) The Wall Street Journal, May 19, 2022
9) The New York Times, May 20, 2022
12) FactSet, 2022

 

What is the Catalent 401(k) Savings Plan?

The Catalent 401(k) Savings Plan is a retirement savings plan that allows employees to save for their future by contributing a portion of their salary on a pre-tax or Roth after-tax basis.

How can I enroll in the Catalent 401(k) Savings Plan?

Employees can enroll in the Catalent 401(k) Savings Plan by accessing the benefits portal or contacting Human Resources for guidance on the enrollment process.

What are the eligibility requirements for the Catalent 401(k) Savings Plan?

To be eligible for the Catalent 401(k) Savings Plan, employees typically need to be at least 21 years old and have completed a specified period of service with the company.

Does Catalent offer a company match for the 401(k) Savings Plan?

Yes, Catalent offers a company match for contributions made to the 401(k) Savings Plan, which helps employees maximize their retirement savings.

How much can I contribute to the Catalent 401(k) Savings Plan?

Employees can contribute up to the IRS annual limit to the Catalent 401(k) Savings Plan, which may vary each year. It’s important to check the current limits.

When can I start making contributions to the Catalent 401(k) Savings Plan?

Employees can start making contributions to the Catalent 401(k) Savings Plan after they complete the eligibility requirements and enroll in the plan.

Can I change my contribution amount in the Catalent 401(k) Savings Plan?

Yes, employees can change their contribution amount at any time during the year by accessing the benefits portal or contacting Human Resources.

What investment options are available in the Catalent 401(k) Savings Plan?

The Catalent 401(k) Savings Plan offers a variety of investment options, including mutual funds and target-date funds, allowing employees to choose based on their risk tolerance and retirement goals.

How often can I change my investment allocations in the Catalent 401(k) Savings Plan?

Employees can change their investment allocations in the Catalent 401(k) Savings Plan at any time, subject to the plan's trading restrictions.

What happens to my Catalent 401(k) Savings Plan if I leave the company?

If you leave Catalent, you have several options for your 401(k) Savings Plan, including rolling it over to another qualified plan, cashing it out, or leaving it in the Catalent plan if permitted.

With the current political climate we are in it is important to keep up with current news and remain knowledgeable about your benefits.
Catalent's Pension Plan: Catalent offers a comprehensive retirement benefits package designed to support its employees' financial wellness. The primary pension plan provided by Catalent is known as the "Catalent Pension Plan." This plan includes a defined benefit formula based on an employee’s years of service and final average pay. Typically, to qualify for the pension plan, employees must have a minimum of five years of service and be at least 55 years of age. The specific pension formula details and eligibility criteria are laid out in the employee benefits documentation provided internally by Catalent​ (Catalent)​ (Catalent Investor Relations)​ (FiercePharma). Catalent's 401(k) Plan: Catalent also offers a 401(k) plan to its employees, which is referred to as the "Catalent 401(k) Savings Plan." Employees are eligible to participate in the 401(k) plan from their first day of employment. The company provides a generous matching contribution, where Catalent matches 50% of the first 6% of the employee's contributions. This plan is designed to help employees save for retirement with the added benefit of tax deferral on contributions and earnings​
Catalent has been undergoing significant restructuring since 2023, including multiple rounds of layoffs affecting various facilities. In late 2023, the company laid off approximately 300 employees as part of a cost-cutting initiative aimed at consolidating its facilities. This was followed by further layoffs in early 2024, including the reduction of 130 staff members at its Bloomington, Indiana site, which is being sold to Novo Nordisk as part of a broader $16.5 billion acquisition deal expected to close by the end of 2024. The restructuring is driven by reduced demand for COVID-19-related services and a need to increase efficiency and reduce costs across its operations. Importance: Addressing this news is crucial due to the current economic environment, where companies are navigating the aftermath of the pandemic, fluctuating demand, and economic pressures. These changes also reflect broader trends in the biopharma industry, where consolidation and cost-cutting measures are common as companies adjust to new market realities​
Stock Options: Catalent offers stock options to its employees as part of its long-term incentive plan. These options are designed to align the interests of employees with those of shareholders. Employees receive the right to purchase company stock at a predetermined price, known as the exercise price, after a specified vesting period. Restricted Stock Units (RSUs): Catalent also provides RSUs to its employees, which represent a promise to deliver shares of the company's stock in the future. RSUs typically vest over a period of time, encouraging employees to remain with the company. Once vested, the RSUs are converted into shares, which the employee can then sell or hold.
Catalent offers a comprehensive suite of health benefits to its employees, designed to meet diverse needs and foster a healthy lifestyle. Their health insurance plans cover a wide range of medical services, emphasizing both personal and financial wellness. Employees have access to wellness programs, which aim to manage healthcare costs and encourage a healthy lifestyle. These programs include health insurance, wellness incentives, and various support resources to balance work and personal life, such as generous paid time off and flexible work arrangements. In 2022, 2023, and 2024, Catalent continued to enhance its benefits offerings, aligning them with industry standards and employee needs. Recent updates include tuition reimbursement, global scholarship programs for employees' children, and comprehensive retirement plans. The company has also been recognized for its commitment to diversity and inclusion, receiving accolades as a “Best Place to Work for People with Disabilities” for consecutive years. Specific healthcare-related terms and acronyms frequently used by Catalent include "OptiDose® Design Solution," "RP Scherer Softgel Technology," and "OneXpress™ Solution," which refer to their proprietary technologies and approaches in pharmaceutical development and manufacturing. Recent employee healthcare news highlights Catalent's ongoing efforts to support employee well-being. For instance, their 2023 Corporate Responsibility Report details initiatives in employee health and wellness, such as investments in diverse and inclusive workplace practices and contributions to STEM education
New call-to-action

Additional Articles

Check Out Articles for Catalent employees

Loading...

For more information you can reach the plan administrator for Catalent at 14 Schoolhouse Road Somerset, NJ 8873; or by calling them at +1 908-809-1300.

https://www.thelayoff.com/catalent https://www.fiercepharma.com/pharma/catalent-unveils-recent-300-person-layoff-round-it-awaits-165b-novo-buyout https://bloomingtonian.com/2023/05/31/catalent-to-cut-another-150-positions-and-reorganize-in-bloomington-indiana/ https://indianapublicmedia.org/news/catalent-cutting-130-positions-at-bloomington-facility-this-week.php https://investor.catalent.com/financial-news/news-details/2024/Catalent-Inc.-Reports-Third-Quarter-Fiscal-2024-Results/default.aspx https://careers.catalent.com/us/en/benefits https://www.cashbalancedesign.com/resources/contribution-limits/ https://www.emparion.com/cash-balance-pension-plan-faq/ https://www.kiplinger.com/retirement/cash-balance-pension-plan-options https://www.futureplan.com/resources/news-articles/defined-benefit-cash-balance-plan-key-priorities/ https://investor.catalent.com/financial-news/news-details/2023/Catalent-Inc.-Reports-Preliminary-First-Quarter-Fiscal-2024-Results-and-Reaffirms-Full-Year-Fiscal-2024-Guidance/default.aspx https://careers.catalent.com/us/en/benefits https://www.fiercepharma.com/pharma/catalent-unveils-recent-300-person-layoff-round-it-awaits-165b-novo-buyout https://investor.catalent.com/ https://investor.catalent.com/financial-news/news-details/2023/Catalent-Inc.-Reports-Preliminary-Fourth-Quarter-and-Fiscal-2023-Results/default.aspx https://www.catalent.com/catalent-news/catalent-publishes-fourth-annual-corporate-responsibility-report/ https://annualreport.stocklight.com/nyse/ctlt/231007947.pdf https://creativeplanning.com/insights/financial-planning/how-to-use-the-net-unrealized-appreciation-nua-strategy-in-your-401k/ https://carlsoncap.com/articles/nua-net-unrealized-appreciation/ https://www.fidelity.com/learning-center/personal-finance/retirement/company-stock https://turbotax.intuit.com/tax-tips/retirement/net-unrealized-appreciation-nua-tax-treatment-amp-strategies/c71vBJZ2B https://investor.catalent.com/financial-news/news-details/2024/Novo-Holdings-to-Acquire-Catalent/default.aspx https://www.catalent.com/catalent-news/novo-holdings-to-acquire-catalent/ https://www.dcatvci.org/features/manufacturing-fallout-of-novos-16-5-billion-acquisition-of-catalent/ https://www.fiercepharma.com/pharma/catalent-unveils-recent-300-person-layoff-round-it-awaits-165b-novo-buyout https://www.thelayoff.com/t/1kgvERTs https://contracts.justia.com/ https://www.sec.gov/

*Please see disclaimer for more information

Relevant Articles

Check Out Articles for Catalent employees